FDA Approves ISEMBYLD™ for People Living with SMA
RegulatoryapprovedISEMBYLDPositive
AI Analysis
Summary
The FDA approved Scholar Rock's ISEMBYLD (apitegromab-mstn) for treating people living with spinal muscular atrophy. This regulatory approval represents a significant milestone for SMA treatment options.
Outcome Details
FDA approval of ISEMBYLD (apitegromab-mstn) for people living with SMA
Importance:9/10
Sentiment:
0.95
FDA approvalSMAspinal muscular atrophyScholar RockISEMBYLDapitegromab-mstn
Read the original article
Published by PR Newswire Biotech on September 14, 2026 2:07 PM